All Stories

  1. Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes

    Article • Medical Devices Evidence and Research, July 2015, Dove Medical Press

    Dr Vasileios F Panoulas

  2. Two-Year Follow-Up OCT Images of 2 Bifurcation Lesions Treated With Bioresorbable Vascular Scaffolds

    Article • JACC Cardiovascular Imaging, May 2015, Elsevier

    Dr Vasileios F Panoulas

  3. A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study

    Article • International Journal of Cardiology, April 2015, Elsevier

    Dr Vasileios F Panoulas

  4. The role of TNF-α, Fas/Fas ligand system and NT-proBNP in the early detection of asymptomatic left ventricular dysfunction in cancer patients treated with anthracyclines

    Article • IJC Heart & Vasculature, March 2015, Elsevier

    Dr Vasileios F Panoulas

  5. Procedural Feasibility and Clinical Outcomes in Propensity-Matched Patients Treated With Bioresorbable Scaffolds vs New-Generation Drug-Eluting Stents

    Article • Canadian Journal of Cardiology, March 2015, Elsevier

    Dr Vasileios F Panoulas

  6. Transcatheter aortic valve implantation with a Direct Flow Medical valve in a patient with severe aortic regurgitation due to degenerated aortic stentless bioprosthesis

    Article • International Journal of Cardiology, March 2015, Elsevier

    Dr Vasileios F Panoulas

  7. Bioresorbable scaffolds for the treatment of complex lesions: are we there yet?

    Article • Interventional Cardiology, February 2015, OMICS Publishing Group

    Dr Vasileios F Panoulas

  8. Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation

    Article • International Journal of Cardiology, February 2015, Elsevier

    Dr Vasileios F Panoulas, Dr Pietro Spagnolo

  9. Comparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt-chromium alloy stents in real-world diabetic patients

    Article • Catheterization and Cardiovascular Interventions, January 2015, Wiley

    Dr Vasileios F Panoulas

  10. Association Between Corrected QT Interval and Inflammatory Cytokines in Rheumatoid Arthritis

    Article • The Journal of Rheumatology, January 2015, The Journal of Rheumatology

    Dr Vasileios F Panoulas

  11. Diagnostic Coronary Angiography Is Getting Old!∗

    Article • JACC Cardiovascular Imaging, January 2015, Elsevier

    Dr Vasileios F Panoulas

  12. Hybrid Coronary Revascularization

    Article • Journal of the American College of Cardiology, January 2015, Elsevier

    Dr Vasileios F Panoulas

  13. Side Branch Occlusion After Bioresorbable Vascular Scaffold Implantation

    Article • JACC Cardiovascular Interventions, January 2015, Elsevier

    Dr Vasileios F Panoulas

  14. In-Scaffold Restenosis in a Previous Left Main Bifurcation Lesion Treated With Bioresorbable Scaffold V-Stenting

    Article • JACC Cardiovascular Interventions, January 2015, Elsevier

    Dr Vasileios F Panoulas

  15. Short-term outcomes following “full-plastic jacket” everolimus-eluting bioresorbable scaffold implantation

    Article • International Journal of Cardiology, December 2014, Elsevier

    Dr Vasileios F Panoulas

  16. Early detection of subclinical left ventricular myocardial dysfunction in patients with chronic kidney disease

    Article • European Heart Journal - Cardiovascular Imaging, November 2014, European Society of Cardiology

    Dr Vasileios F Panoulas

  17. Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis

    Article • Atherosclerosis, November 2014, Elsevier

    Dr Vasileios F Panoulas

  18. Optimal Duration of Dual Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: Lessons From Optical Coherence Tomography

    Article • Canadian Journal of Cardiology, November 2014, Elsevier

    Dr Vasileios F Panoulas

  19. One-Year Follow-Up Optical Coherence Tomography After Implantation of Bioresorbable Vascular Scaffolds for a Chronic Coronary Total Occlusion

    Article • JACC Cardiovascular Interventions, October 2014, Elsevier

    Dr Vasileios F Panoulas

  20. Why Do We Need Post-Dilation After Implantation of a Bioresorbable Vascular Scaffold Even for a Soft Lesion?

    Article • JACC Cardiovascular Interventions, September 2014, Elsevier

    Dr Vasileios F Panoulas

  21. TCT-776 Risk Factors And Clinical Significance Of Intra-Procedural Haemodynamic Instability In Patients Undergoing Transcatheter Aortic Valve Implantation

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas, Dr Pietro Spagnolo

  22. TCT-705 Trascatheter Aortic Valve Implantation Outcomes With Self-Expandable and Balloon-Expandable Devices in Patients with Mixed Aortic Valve Stenosis

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas, Dr Pietro Spagnolo

  23. TCT-612 Clinical outcomes in patients with calcified lesions, treated with bioresorbable vascular scaffolds

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  24. TCT-771 Comparison of post TAVR paravalvular regurgitation between Edwards SAPIEN 3 and Edwards SAPIEN XT; early, single center experience

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas, Dr Pietro Spagnolo

  25. TCT-627 Comparison of Procedural Feasibility Between Bioresorbable Vascular Scaffold and New-generation Drug Eluting Stent in an All-comer Population

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  26. TCT-250 A Comparison of Cobalt-Chromium Alloy Stents: Zotarolimus-eluting and Everolimus-eluting in Patients with Diabetes

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  27. TCT-244 Real World 1-year Clinical Outcomes of Bioresorbable Vascular Scaffold Implanted in Diabetic Patients

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  28. TCT-630 Impact of Calcified Plaque on Stent Strut Distribution of Bioresorbable Vascular Scaffolds Versus Metallic Everolimus-eluting Stents: An Optical Coherence Tomography Analysis

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  29. TCT-631 Clinical Outcome of Patients With Complex Lesion Treated With Bioresorbable Vascular Scaffold; Single Center Experience

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  30. TCT-277 Synergy of Drug Coated Balloons plus Second-generation Drug Eluting Stents versus Second-generation Drug Eluting Stents: A Propensity Matched Analysis

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  31. TCT-284 Synergy of Drug Coated Balloons plus Second-generation Drug Eluting Stents in lesions with high risk for restenosis

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  32. TCT-229 First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: The Milan and New-Tokyo (MITO) registry

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  33. TCT-743 To Predilate or To Not Predilate In Transcatheter Aortic Valve Implantation? Single-Center Experience With Self-Expandable CoreValve Revalving System

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas, Dr Pietro Spagnolo

  34. TCT-296 Routine Screening Of Coronary Artery Disease With Computed Tomography Coronary Angiography In Place Of Invasive Coronary Angiography In Patients Undergoing Transcatheter Aortic Valve Implantation

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas, Dr Pietro Spagnolo

  35. TCT-187 Procedural Feasibility and Clinical Efficacy of Bioresorbable Vascular Scaffold in the Treatment of Bifurcation Lesions: Results from a Single Center Experience

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  36. TCT-609 Comparison of one year outcomes in real world patients treated with a polymer free amphilimus eluting coronary stent versus second generation everolimus eluting stents

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas

  37. TCT-694 Early Outcomes With Direct Flow Medical Versus 1°-Generation Transcatheter Aortic Valve Devices: A Single-Center Propensity-Matched Analysis

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Dr Vasileios F Panoulas, Dr Pietro Spagnolo

  38. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: The Milan and New-Tokyo (MITO) registry

    Article • Catheterization and Cardiovascular Interventions, August 2014, Wiley

    Dr Vasileios F Panoulas

  39. The South Asian Genome

    Article • PLoS ONE, August 2014, PLOS

    Dr Vasileios F Panoulas

  40. Delayed Disruption of a Bioresorbable Vascular Scaffold

    Article • JACC Cardiovascular Imaging, August 2014, Elsevier

    Dr Vasileios F Panoulas

  41. A Case of True Left Main Bifurcation Treated With Bioresorbable Everolimus-Eluting Stent V-Stenting

    Article • JACC Cardiovascular Interventions, August 2014, Elsevier

    Dr Vasileios F Panoulas

  42. Tardive Coronary Obstruction By a Native Leaflet After Transcatheter Aortic Valve Replacement in a Patient With Heavily Calcified Aortic Valve Stenosis

    Article • JACC Cardiovascular Interventions, August 2014, Elsevier

    Dr Vasileios F Panoulas, Dr Pietro Spagnolo

  43. Unanticipated Pseudocoarctation Highlights the Importance of Visualizing Aortic Arch Anatomy Before Transfemoral Transcatheter Aortic Valve Implantation

    Article • Circulation Cardiovascular Interventions, August 2014, Wolters Kluwer Health

    Dr Vasileios F Panoulas

  44. Bioresorbable vascular scaffolds for left main lesions; a novel strategy to overcome limitations

    Article • International Journal of Cardiology, July 2014, Elsevier

    Dr Vasileios F Panoulas

  45. Strategy for optimal side-branch positioning of bioresorbable vascular scaffolds in dedicated 2-stent techniques: Insights from optical coherence tomography

    Article • Cardiovascular Revascularization Medicine, July 2014, Elsevier

    Dr Vasileios F Panoulas

  46. Bioresorbable vascular scaffold strut disruption after crossing with an optical coherence tomography imaging catheter

    Article • International Journal of Cardiology, July 2014, Elsevier

    Dr Vasileios F Panoulas

  47. Acute stent thrombosis of a bioresorbable vascular scaffold implanted for ST-segment elevation myocardial infarction

    Article • International Journal of Cardiology, June 2014, Elsevier

    Dr Vasileios F Panoulas

  48. A case of Kawasaki’s disease with extensive calcifications needing rotational atherectomy with a 2.5mm burr

    Article • Cardiovascular Revascularization Medicine, June 2014, Elsevier

    Dr Vasileios F Panoulas

  49. 111 Investigation of the Validity of Cardiovascular Death Certification Amongst Uk Indian Asians and Europeans

    Article • Heart, May 2014, BMJ

    Dr Vasileios F Panoulas

  50. Conventional surgery and transcatheter closure via surgical transapical approach for paravalvular leak repair in high-risk patients: results from a single-centre experience

    Article • European Heart Journal - Cardiovascular Imaging, May 2014, European Society of Cardiology

    Dr Vasileios F Panoulas

  51. Outcomes in coronary stent trials—1 year is not enough

    Article • Nature Reviews Cardiology, May 2014, Springer Science + Business Media

    Dr Vasileios F Panoulas

  52. After 3 Decades, at Long Last, a New Device to Deal With Calcific Lesions∗

    Article • JACC Cardiovascular Interventions, May 2014, Elsevier

    Dr Vasileios F Panoulas

  53. Prevalence of Electrocardiographic Anomalies in Young Individuals

    Article • Journal of the American College of Cardiology, May 2014, Elsevier

    Dr Vasileios F Panoulas

  54. Hybrid percutaneous coronary revascularisation for a patient with left main bifurcation and extensive, diffuse coronary artery disease

    Article • International Journal of Cardiology, May 2014, Elsevier

    Dr Vasileios F Panoulas

  55. Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis

    Article • International Journal of Cardiology, May 2014, Elsevier

    Dr Vasileios F Panoulas

  56. Is “the bigger the better” still valid for drug-eluting stents?

    Article • Catheterization and Cardiovascular Interventions, April 2014, Wiley

    Dr Vasileios F Panoulas

  57. No more metallic cages: An attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel

    Article • International Journal of Cardiology, April 2014, Elsevier

    Dr Vasileios F Panoulas

  58. First case reported of transcatheter aortic valve implantation in a patient affected by Fabry’s Disease and severe low-flow low-gradient aortic valve stenosis

    Article • Case Reports in Internal Medicine, March 2014, Sciedu Press

    Dr Vasileios F Panoulas, Dr Pietro Spagnolo

  59. The role of intravascular ultrasound and quantitative angiography in the functional assessment of intermediate coronary lesions: Correlation with fractional flow reserve

    Article • Cardiovascular Revascularization Medicine, January 2014, Elsevier

    Dr Vasileios F Panoulas

  60. Coronary heart disease in Indian Asians

    Article • Global Cardiology Science and Practice, January 2014, QScience

    Dr Vasileios F Panoulas

  61. Poster session Thursday 12 December - PM: 12/12/2013, 14:00-18:00 * Location: Poster area

    Article • European Heart Journal - Cardiovascular Imaging, December 2013, European Society of Cardiology

    Dr Vasileios F Panoulas

  62. Poster Session Saturday 14 December - AM: 14/12/2013, 08:30-12:30 * Location: Poster area

    Article • European Heart Journal - Cardiovascular Imaging, December 2013, European Society of Cardiology

    Dr Vasileios F Panoulas

  63. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden

    Article • Rheumatology, October 2013, Oxford University Press (OUP)

    Dr Vasileios F Panoulas

  64. Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors

    Article • Clinical Rheumatology, May 2013, Springer Science + Business Media

    Dr Vasileios F Panoulas

  65. Iatrogenic communications between aortic root and right ventricle/left atrium after transcatheter aortic valve replacement

    Article • Catheterization and Cardiovascular Interventions, April 2013, Wiley

    Dr Vasileios F Panoulas

  66. Physiological Right Ventricular Adaptation in Elite Athletes of African and Afro-Caribbean Origin

    Article • Circulation, March 2013, Wolters Kluwer Health

    Dr Vasileios F Panoulas

  67. SUBCLINICAL ABNORMALITIES OF LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND NORMAL LEFT VENTRICULAR EJECTION FRACTION

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Dr Vasileios F Panoulas

  68. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes?

    Article • Heart, February 2013, BMJ

    Dr Vasileios F Panoulas

  69. Cardiac adaptation to exercise in adolescent athletes of African ethnicity: an emergent elite athletic population

    Article • British Journal of Sports Medicine, January 2013, BMJ

    Dr Vasileios F Panoulas

  70. Poster Session: Right ventricular systolic function

    Article • European Heart Journal - Cardiovascular Imaging, December 2012, European Society of Cardiology

    Dr Vasileios F Panoulas

  71. Tuesday, 28 August 2012

    Article • European Heart Journal, August 2012, European Society of Cardiology

    Dr Vasileios F Panoulas, Professor Valentina Kutyifa, Dr Alberto Bouzas-Mosquera

  72. Investigating novel regulators and inhibitors of aortic valve calcification

    Article • European Heart Journal, August 2012, European Society of Cardiology

    Dr Vasileios F Panoulas, Mrs Maria Å Liljeroos, Mr Daniel A Lerman

  73. Pocket-size hand-held cardiac ultrasound as an adjunct to clinical examination in the hands of medical students and junior doctors

    Article • European Heart Journal - Cardiovascular Imaging, July 2012, European Society of Cardiology

    Dr Vasileios F Panoulas

  74. 102 Pocket-size hand-held cardiac ultrasound in the hands of students and junior doctors: does it improve diagnostic accuracy over history, physical examination and ECG?

    Article • Heart, May 2012, BMJ

    Dr Vasileios F Panoulas

  75. 061 QT prolongation associates with increased mortality in patients with rheumatoid arthritis

    Article • Heart, May 2012, BMJ

    Dr Vasileios F Panoulas

  76. 074 The prevalence and significance of left ventricular hypertrabeculation in highly trained athletes

    Article • Heart, May 2012, BMJ

    Dr Vasileios F Panoulas

  77. Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritis

    Article • Rheumatology International, March 2012, Springer Science + Business Media

    Dr Vasileios F Panoulas

  78. Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis

    Article • Arthritis Research & Therapy, January 2012, Springer Science + Business Media

    Dr Vasileios F Panoulas

  79. Apolipoprotein E Gene Polymorphisms Are Strong Predictors of Inflammation and Dyslipidemia in Rheumatoid Arthritis

    Article • The Journal of Rheumatology, December 2011, The Journal of Rheumatology

    Dr Vasileios F Panoulas

  80. Poster Session 4: Friday 9 December 2011, 14:00-18:00 * Location: Poster Area

    Article • European Journal of Echocardiography, November 2011, European Society of Cardiology

    Dr Vasileios F Panoulas, Professor Valentina Kutyifa

  81. 49 Ethnic variation in QT interval among highly trained athletes

    Article • Heart, June 2011, BMJ

    Dr Vasileios F Panoulas

  82. 60 Ethnic differences in repolarisation patterns and left ventricular remodelling in highly trained male adolescent (14-18 years) athletes

    Article • Heart, June 2011, BMJ

    Dr Vasileios F Panoulas

  83. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin

    Article • European Heart Journal, May 2011, European Society of Cardiology

    Dr Vasileios F Panoulas

  84. Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis

    Article • Journal of Human Hypertension, April 2011, Springer Science + Business Media

    Dr Vasileios F Panoulas

  85. Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis

    Article • Annals of the Rheumatic Diseases, March 2011, BMJ

    Dr Vasileios F Panoulas

  86. Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis

    Article • Arthritis Research & Therapy, January 2011, Springer Science + Business Media

    Dr Vasileios F Panoulas, Alan M Nevill

  87. Subclinical peripheral arterial disease in rheumatoid arthritis

    Article • Atherosclerosis, September 2010, Elsevier

    Dr Vasileios F Panoulas

  88. The relationship of systemic right ventricular function to ECG parameters and NT-proBNP levels in adults with transposition of the great arteries late after Senning or Mustard surgery

    Article • Heart, August 2010, BMJ

    Dr Vasileios F Panoulas

  89. Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis?

    Article • Angiology, August 2010, SAGE Publications

    Dr Vasileios F Panoulas

  90. Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation

    Article • Clinical Rheumatology, April 2010, Springer Science + Business Media

    Dr Vasileios F Panoulas

  91. Genetics [315-318]: 315. Investigation of Association of the Erap1 Gene with Psoriatic Arthritis

    Article • Rheumatology, March 2010, Oxford University Press (OUP)

    Dr Vasileios F Panoulas

  92. Rheumatoid Arthritis: Clinical Aspects [322-355]: 322. The Effect of Biologics on Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Systematic Literature Review

    Article • Rheumatology, March 2010, Oxford University Press (OUP)

    Dr Vasileios F Panoulas

  93. Cytokines and Inflammatory Mediators [30-39]: 30. The LPS Stimulated Production of Interleukin-10 is not Associated with -819C/T and -592C/A Promoter Polymorphisms in Healthy Indian Subjects

    Article • Rheumatology, March 2010, Oxford University Press (OUP)

    Dr Vasileios F Panoulas

  94. Target organ damage in patients with rheumatoid arthritis: The role of blood pressure and heart rate

    Article • Atherosclerosis, March 2010, Elsevier

    Dr Vasileios F Panoulas

  95. What predicts obesity in patients with rheumatoid arthritis? An investigation of the interactions between lifestyle and inflammation

    Article • International Journal of Obesity, October 2009, Springer Science + Business Media

    Dr Vasileios F Panoulas

  96. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

    Article • Annals of the Rheumatic Diseases, October 2009, BMJ

    Dr Vasileios F Panoulas

  97. Development and initial validation of a heart disease knowledge questionnaire for people with rheumatoid arthritis

    Article • Patient Education and Counseling, October 2009, Elsevier

    Dr Vasileios F Panoulas

  98. The magnitude of sudden cardiac death in the young: a death certificate-based review in England and Wales

    Article • EP Europace, August 2009, European Society of Cardiology

    Dr Vasileios F Panoulas

  99. Prevalence of risk factors for statin-induced myopathy in rheumatoid arthritis patients

    Article • Musculoskeletal Care, July 2009, Wiley

    Dr Vasileios F Panoulas

  100. Atherosclerosis in Rheumatoid Arthritis Versus Diabetes: A Comparative Study

    Article • Arteriosclerosis Thrombosis and Vascular Biology, July 2009, Wolters Kluwer Health

    Dr Vasileios F Panoulas

  101. Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival

    Article • Neurology, May 2009, Wolters Kluwer Health

    Dr Vasileios F Panoulas

  102. Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: The role of obesity and smoking

    Article • Atherosclerosis, May 2009, Elsevier

    Dr Vasileios F Panoulas

  103. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis

    Article • European Journal of Cardiovascular Prevention & Rehabilitation, April 2009, SAGE Publications

    Dr Vasileios F Panoulas, Alan M Nevill

  104. Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis: Table 1

    Article • Annals of the Rheumatic Diseases, March 2009, BMJ

    Dr Vasileios F Panoulas

  105. Heart Disease Fact Questionnaire—Rheumatoid Arthritis

    Article • January 2009, American Psychological Association (APA)

    Dr Vasileios F Panoulas

  106. Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis

    Article • Arthritis & Rheumatism, January 2009, Wiley

    Dr Vasileios F Panoulas

  107. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study

    Article • Arthritis Research & Therapy, January 2009, Springer Science + Business Media

    Dr Vasileios F Panoulas

  108. Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis

    Article • Arthritis Research & Therapy, January 2009, Springer Science + Business Media

    Dr Vasileios F Panoulas

  109. Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome - authors' response

    Article • Arthritis Research & Therapy, January 2009, Springer Science + Business Media

    Dr Vasileios F Panoulas

  110. Galectin-2(LGALS2)3279C/T Polymorphism may be Independently Associated with Diastolic Blood Pressure in Patients with Rheumatoid Arthritis

    Article • Clinical and Experimental Hypertension, January 2009, Taylor & Francis

    Dr Vasileios F Panoulas

  111. Lack of an Association of GNB3 C825T Polymorphism and Blood Pressure in Patients with Rheumatoid Arthritis

    Article • Clinical and Experimental Hypertension, January 2009, Taylor & Francis

    Dr Vasileios F Panoulas

  112. Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis

    Article • Clinical Rheumatology, December 2008, Springer Science + Business Media

    Dr Vasileios F Panoulas, Alan M Nevill

  113. Transforming growth factor- 1 869T/C, but not interleukin-6 -174G/C, polymorphism associates with hypertension in rheumatoid arthritis

    Article • Rheumatology, November 2008, Oxford University Press (OUP)

    Dr Vasileios F Panoulas

  114. “Cardiovascular” Drugs in Rheumatoid Arthritis: Killing Two Birds with One Stone?

    Article • Immunology Endocrine & Metabolic Agents - Medicinal Chemistry, September 2008, Bentham Science Publishers

    Dr Vasileios F Panoulas

  115. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis

    Article • Annals of the Rheumatic Diseases, August 2008, BMJ

    Dr Vasileios F Panoulas, Alan M Nevill

  116. The inter-operator variability in measuring waist circumference and its potential impact on the diagnosis of the metabolic syndrome

    Article • Postgraduate Medical Journal, July 2008, BMJ

    Dr Vasileios F Panoulas

  117. Metabolism in Patients with Rheumatoid Arthritis: Resting Energy Expenditure, Physical Activity and Diet-Induced Thermogenesis. Invited Review

    Article • Recent Patents on Endocrine Metabolic & Immune Drug Discovery, June 2008, Bentham Science Publishers

    Dr Vasileios F Panoulas

  118. Hypertension in rheumatoid arthritis

    Article • Rheumatology, April 2008, Oxford University Press (OUP)

    Dr Vasileios F Panoulas

  119. Six-step management of hypertension in patients with rheumatoid arthritis

    Article • Future Rheumatology, February 2008, Future Medicine

    Dr Vasileios F Panoulas

  120. Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis

    Article • Annals of the Rheumatic Diseases, January 2008, BMJ

    Dr Vasileios F Panoulas

  121. Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study

    Article • Arthritis Research & Therapy, January 2008, Springer Science + Business Media

    Dr Vasileios F Panoulas, Alan M Nevill

  122. Polymorphisms of the Endothelin-1 Gene Associate with Hypertension in Patients with Rheumatoid Arthritis

    Article • Endothelium, January 2008, Taylor & Francis

    Dr Vasileios F Panoulas

  123. Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross sectional study

    Article • Arthritis Research & Therapy, January 2008, Springer Science + Business Media

    Dr Vasileios F Panoulas

  124. Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis

    Article • Rheumatology, January 2008, Oxford University Press (OUP)

    Dr Vasileios F Panoulas

  125. New resting energy expenditure prediction equations for patients with rheumatoid arthritis

    Article • Rheumatology, December 2007, Oxford University Press (OUP)

    Dr Vasileios F Panoulas, Alan M Nevill

  126. Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review

    Article • Rheumatology, November 2007, Oxford University Press (OUP)

    Dr Vasileios F Panoulas

  127. Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis

    Article • Journal of Human Hypertension, October 2007, Springer Science + Business Media

    Dr Vasileios F Panoulas

  128. Blockade of tumour necrosis factor-  in rheumatoid arthritis: effects on components of rheumatoid cachexia

    Article • Rheumatology, August 2007, Oxford University Press (OUP)

    Dr Vasileios F Panoulas, Alan M Nevill

  129. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis

    Article • Rheumatology, June 2007, Oxford University Press (OUP)

    Dr Vasileios F Panoulas

  130. Association of serum uric acid with cardiovascular disease in rheumatoid arthritis

    Article • Rheumatology, June 2007, Oxford University Press (OUP)

    Dr Vasileios F Panoulas

  131. Polypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidity

    Article • Musculoskeletal Care, January 2007, Wiley

    Dr Vasileios F Panoulas, Józef Iwaszko

  132. B-cell differentiation immunophenotypes in classical Hodgkin lymphomas

    Article • Leukemia & Lymphoma, January 2006, Taylor & Francis

    Dr Vasileios F Panoulas